ND Acquisitions Corp., dba NuScriptRX, formerly New Day Pharmacy, is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and patients. The company packages and delivers medications to long-term care facilities and their patients after receiving orders from physicians.
Missing: NuScriptRX's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: NuScriptRX's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing NuScriptRX
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
NuScriptRX is included in 1 Expert Collection, including Pharma Supply Chain.
Pharma Supply Chain
Latest NuScriptRX News
Aug 28, 2012
NuScriptRX Closes $5 Mln in Series C Add-On August 27, 2012 Follow @luisarbeltran NuScriptRX received $5 million in Series C add-on led by Council Capital and its TNInvestco arm, Council & Enhanced Tennessee Fund. Existing investors in the Series C round include Clayton Associates of Nashville, Tenn., Council Operating Partner Linwood A. (Chip) Lacy Jr. and Envest of Virginia Beach, Va. Nashville-based NuScriptrx is a mail order institutional pharmacy. PRESS RELEASE NuScriptRX, the Nashville-based mail order institutional pharmacy, has closed on a $5 million Series C add-on led by Council Capital and its TNInvestco arm, Council & Enhanced Tennessee Fund. In addition to Council Capital and the Tennessee Fund, the Series C round includes other existing investors: Clayton Associates of Nashville, Tenn., Council Operating Partner Linwood A. (Chip) Lacy, Jr., Envest of Virginia Beach, Va., three other TNInvestco funds – Nest-TN of Tullahoma, Tenn., Tennessee Angel Fund of Nashville, Tenn. (an affiliate of Nashville Capital Network) and Innova of Memphis, Tenn., and an additional unnamed strategic investor. “This new capital will allow NuScriptRX to sustain the strong momentum it is currently enjoying while also building the infrastructure and operational excellence to manage the growth,” said Dennis Bottorff, chairman of the NuScriptRX board of directors and Managing General Partner of Capital Council.”With the growth in the elderly population and increasing dissatisfaction with the cost and quality of service from the current pharmacy model, NuScriptRX is clearly on the right side of change in healthcare.” The company, which has quadrupled its revenue run-rate to over $30 million in the past 18 months, uses automated dispensing systems to improve productivity and administration of prescriptions through its single location in Nashville. NuScriptRX last week announced a new management team led by acting CEO Donald B. Taylor, a NuScriptRX board member and member of Council Capital’s CEO Council, and Jim Beaumariage, a 25-year veteran in pharmacy and healthcare management. “As a company with investments from four TNInvestco companies, NuScriptRX is a great example of delivering on the 2009 state legislation intended to jump start job creation in sectors of the economy with high growth potential. NuScriptRX has created over 60 Tennessee jobs, more than any other TNInvestco company, and has nearly doubled the size of its Nashville central pharmacy,” said Council Capital’s Rick Apple, new director of the Tennessee Fund. About NuScriptRX NuScriptRx is able to reduce cost while improving medication access without the geographic limitations of the traditional courier-based delivery model. By deploying its’ proprietary eMed-StatTM and PharmComTM medication access and communications technologies, NuScriptRX provides timely, cost-effective and safer administration of medicines to long-term care nursing facilities in eight states from one pharmacy center in Nashville,Tenn. This enables the company to provide a higher level of service while saving customers money through reduced drug waste and improved access to medication 24 hours a day, 7 days a week. Additional information on NuScriptRX can be accessed at www.nuscriptrx.com. © 2015 Buyouts Insider / Argosy Group LLC
NuScriptRX Frequently Asked Questions (FAQ)
Where is NuScriptRX's headquarters?
NuScriptRX's headquarters is located at 5215 Linbar Drive, Nashville.
What is NuScriptRX's latest funding round?
NuScriptRX's latest funding round is Series D - II.
How much did NuScriptRX raise?
NuScriptRX raised a total of $44.95M.
Who are the investors of NuScriptRX?
Investors of NuScriptRX include Council Capital, Envest Private Equity, Nashville Capital Network, Innova Memphis, Clayton Associates and 5 more.
Who are NuScriptRX's competitors?
Competitors of NuScriptRX include Pharmaca Integrative Pharmacy, RxStrategies, IntegriChain, PharMEDium Healthcare Holdings, Remedi Seniorcare and 8 more.
Compare NuScriptRX to Competitors
Apex Pharmacies Ltd. was founded in 2004. The Apex business plan involves bringing together experienced pharmacy operators with financial professionals and ensuring access to capital. Apex will acquire highly sought after pharmacy targets in Western Canada at a pace that aims to allow integration of these acquisitions into the overall Apex chain, while maintaining strong bottom line performance. www.apexpharmacies.com .
IntegriChain is a channel management cloud used by life sciences suppliers, including nine of the top 10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems.
Remedi SeniorCare delivers comprehensive pharmacy services, pharmacy consulting, and data management services to nursing homes, assisted living, and continuing care retirement communities. The business is committed to helping these organizations achieve outstanding care, financial strength, and medication safety. Remedi combines their culture of caring with real-world pharmacy services and best-in-class technology to give organizations more time and resources and help them focus on caring for their residents.
RxStrategies is a provider of discounted prescription medicines.
SFJ Pharmaceuticals is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products. SFJ Pharmaceuticals provides a financially advantageous and creative alternative approach to partnering. The comapny can provide the strategic financing, clinical development and regulatory resources for the clinical development and approval of products. SFJ Pharmaceuticals is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products.
ForHealth Technologies is a manufacturer of pharmacy-based systems that aim to automate the preparation of sterile, intravenous medications.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.